{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:58:02Z","timestamp":1789059482957,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,9,29]],"date-time":"2010-09-29T00:00:00Z","timestamp":1285718400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Psychiatry Rep"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s11920-010-0157-z","type":"journal-article","created":{"date-parts":[[2010,9,28]],"date-time":"2010-09-28T01:44:19Z","timestamp":1285638259000},"page":"512-521","source":"Crossref","is-referenced-by-count":17,"title":["Switching to Hypomania and Mania: Differential Neurochemical, Neuropsychological, and Pharmacologic Triggers and Their Mechanisms"],"prefix":"10.1007","volume":"12","author":[{"given":"Jun","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiru","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kemp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph R.","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,29]]},"reference":[{"key":"157_CR1","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Gao K, Kemp D, Calabrese J: Pharmacological treatment of the maintenance phase of bipolar depression: focus on relapse prevention studies and the impact of design on generalizability. In Bipolar Depression: Molecular Neurobiology, Clinical Diagnosis and Pharmacotherapy. Edited by Zarate CA Jr, Manji HK. Basel, Switzerland: Birkhauser Verlag AT; 2009:159\u2013178. This book chapter summarizes the limitations of the current data in the maintenance treatment of BPD.","DOI":"10.1007\/978-3-7643-8567-5_10"},{"key":"157_CR2","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1742-1241.2009.02284.x","volume":"64","author":"K Gao","year":"2010","unstructured":"Gao K, Kemp DE, Conroy C, et al.: Comorbid anxiety and substance use disorders associated with a lower use of mood stabilisers in patients with rapid cycling bipolar disorder: a descriptive analysis of the cross-sectional data of 566 patients. Int J Clin Pract 2010, 64:336\u2013344.","journal-title":"Int J Clin Pract"},{"key":"157_CR3","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1176\/ps.2007.58.1.85","volume":"58","author":"RJ Baldessarini","year":"2007","unstructured":"Baldessarini RJ, Leahy L, Arcona S, et al.: Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv 2007, 58:85\u201391.","journal-title":"Psychiatr Serv"},{"key":"157_CR4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1172\/JCI37703","volume":"119","author":"K Martinowich","year":"2009","unstructured":"\u2022 Martinowich K, Schloesser RJ, Manji HK: Bipolar disorder: from genes to behavior pathways. J Clin Invest 2009, 119:726\u2013736. This is a good review of the neurobiology of BPD.","journal-title":"J Clin Invest"},{"key":"157_CR5","doi-asserted-by":"crossref","unstructured":"Schildkraut JJ: The catecholamine hypothesis of affective disorders: a review of supporting evidence. 1965. J Neuropsychiatry Clin Neurosci 1995, 7:524\u2013533; discussion 523\u2013524.","DOI":"10.1176\/jnp.7.4.524"},{"key":"157_CR6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0165-0327(94)00094-P","volume":"33","author":"PR Joyce","year":"1995","unstructured":"Joyce PR, Fergusson DM, Woollard G, et al.: Urinary catecholamines and plasma hormones predict mood state in rapid cycling bipolar affective disorder. J Affect Disord 1995, 33:233\u2013243.","journal-title":"J Affect Disord"},{"issue":"Suppl 1","key":"157_CR7","doi-asserted-by":"crossref","first-page":"i6","DOI":"10.1093\/cercor\/bhm033","volume":"17","author":"AF Arnsten","year":"2007","unstructured":"Arnsten AF: Catecholamine and second messenger influences on prefrontal cortical networks of \u201crepresentational knowledge\u201d: a rational bridge between genetics and the symptoms of mental illness. Cereb Cortex 2007, 17(Suppl 1):i6\u2013i15.","journal-title":"Cereb Cortex"},{"key":"157_CR8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0447.2007.01058.x","volume":"434","author":"M Berk","year":"2007","unstructured":"Berk M, Dodd S, Kauer-Sant\u2019anna M, et al.: Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand Suppl 2007, 434:41\u201349.","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"157_CR9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1399-5618.2000.020201.x","volume":"2","author":"IS Shiah","year":"2000","unstructured":"Shiah IS, Yatham LN: Serotonin in mania and in the mechanism of action of mood stabilizers: a review of clinical studies. Bipolar Disord 2000, 2:77\u201392.","journal-title":"Bipolar Disord"},{"key":"157_CR10","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1034\/j.1399-5618.2002.01217.x","volume":"4","author":"S Sobczak","year":"2002","unstructured":"Sobczak S, Honig A, van Duinen MA, et al.: Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies. Bipolar Disord 2002, 4:347\u2013356.","journal-title":"Bipolar Disord"},{"key":"157_CR11","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/j.1399-5618.2007.00466.x","volume":"9","author":"J Applebaum","year":"2007","unstructured":"Applebaum J, Bersudsky Y, Klein E: Rapid tryptophan depletion as a treatment for acute mania: a double-blind, pilot-controlled study. Bipolar Disord 2007, 9:884\u2013887.","journal-title":"Bipolar Disord"},{"key":"157_CR12","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00006842-197405000-00008","volume":"36","author":"DS Janowsky","year":"1974","unstructured":"Janowsky DS, el-Yousef MK, Davis JM: Acetylcholine and depression. Psychosom Med 1974, 36:248\u2013257.","journal-title":"Psychosom Med"},{"key":"157_CR13","doi-asserted-by":"crossref","unstructured":"Eden Evins A, Demopulos C, Nierenberg A, et al.: A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania. Bipolar Disord 2006, 8:75\u201380.","DOI":"10.1111\/j.1399-5618.2006.00243.x"},{"key":"157_CR14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0278-5846(90)90030-K","volume":"14","author":"DB Leiva","year":"1990","unstructured":"Leiva DB: The neurochemistry of mania: a hypothesis of etiology and rationale for treatment. Prog Neuropsychopharmacol Biol Psychiatry 1990, 14:423\u2013429.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"157_CR15","doi-asserted-by":"crossref","unstructured":"Brambilla P, Perez J, Barale F, et al.: GABAergic dysfunction in mood disorders. Mol Psychiatry 2003, 8:721\u2013737, 715.","DOI":"10.1038\/sj.mp.4001362"},{"key":"157_CR16","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.biopsych.2006.08.048","volume":"61","author":"Z Bhagwagar","year":"2007","unstructured":"Bhagwagar Z, Wylezinska M, Jezzard P, et al.: Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar subjects. Biol Psychiatry 2007, 61:806\u2013812.","journal-title":"Biol Psychiatry"},{"key":"157_CR17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.pnpbp.2008.12.025","volume":"33","author":"RE Kaufman","year":"2009","unstructured":"Kaufman RE, Ostacher MJ, Marks EH, et al.: Brain GABA levels in patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:427\u2013434.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"157_CR18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-0327(02)00317-8","volume":"78","author":"F Curtin","year":"2004","unstructured":"Curtin F, Schulz P: Clonazepam and lorazepam in acute mania: a Bayesian meta-analysis. J Affect Disord 2004, 78:201\u2013208.","journal-title":"J Affect Disord"},{"key":"157_CR19","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/npp.2009.191","volume":"35","author":"BP Brennan","year":"2009","unstructured":"\u2022 Brennan BP, Hudson JI, Jensen JE, et al.: Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole. Neuropsychopharmacology 2009, 35:834\u2013846. The data from this study showed that open-label treatment with riluzole increased glutamine\/glutamate ratios and levels of N-acetylaspartate in the anterior cingulate cortex. The reduction of depressive symptoms was positively associated with increases in N-acetylaspartate in the anterior cingulate cortex.","journal-title":"Neuropsychopharmacology"},{"key":"157_CR20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.mp.4002130","volume":"14","author":"MJ Lan","year":"2009","unstructured":"Lan MJ, McLoughlin GA, Griffin JL, et al.: Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder. Mol Psychiatry 2009, 14:269\u2013279.","journal-title":"Mol Psychiatry"},{"key":"157_CR21","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1192\/bjp.184.6.496","volume":"184","author":"S Watson","year":"2004","unstructured":"Watson S, Gallagher P, Ritchie JC, et al.: Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry 2004, 184:496\u2013502.","journal-title":"Br J Psychiatry"},{"key":"157_CR22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000118071","volume":"11","author":"M Maj","year":"1984","unstructured":"Maj M, Ariano MG, Arena F, et al.: Plasma cortisol, catecholamine and cyclic AMP levels, response to dexamethasone suppression test and platelet MAO activity in manic-depressive patients. A longitudinal study. Neuropsychobiology 1984, 11:168\u2013173.","journal-title":"Neuropsychobiology"},{"key":"157_CR23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1600-0447.1992.tb01468.x","volume":"85","author":"AC Swann","year":"1992","unstructured":"Swann AC, Stokes PE, Casper R, et al.: Hypothalamic-pituitary-adrenocortical function in mixed and pure mania. Acta Psychiatr Scand 1992, 85:270\u2013274.","journal-title":"Acta Psychiatr Scand"},{"key":"157_CR24","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/sj.npp.1300471","volume":"29","author":"AH Young","year":"2004","unstructured":"Young AH, Gallagher P, Watson S, et al.: Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology 2004, 29:1538\u20131545.","journal-title":"Neuropsychopharmacology"},{"key":"157_CR25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1399-5618.2008.00647.x","volume":"11","author":"AT Spijker","year":"2009","unstructured":"\u2022 Spijker AT, van Rossum EF, Hoencamp E, et al.: Functional polymorphism of the glucocorticoid receptor gene associates with mania and hypomania in bipolar disorder. Bipolar Disord 2009, 11:95\u2013101. Two variants of the glucocorticoid receptor gene were found to be associated with a protective effect on the manifestation of BPD, suggesting that a subgroup of patients may be vulnerable to manic\/hypomanic switching.","journal-title":"Bipolar Disord"},{"key":"157_CR26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0165-1781(80)90077-3","volume":"2","author":"I Extein","year":"1980","unstructured":"Extein I, Pottash AL, Gold MS, et al.: The thyroid-stimulating hormone response to thyrotropin-releasing hormone in mania and bipolar depression. Psychiatry Res 1980, 2:199\u2013204.","journal-title":"Psychiatry Res"},{"key":"157_CR27","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1001\/archpsyc.1978.01770320111011","volume":"35","author":"C Kirkegaard","year":"1978","unstructured":"Kirkegaard C, Bjorum N, Cohn D, et al.: Thyrotrophin-releasing hormone (TRH) stimulation test in manic-depressive illness. Arch Gen Psychiatry 1978, 35:1017\u20131021.","journal-title":"Arch Gen Psychiatry"},{"key":"157_CR28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-2000-7973","volume":"33","author":"R Bottlender","year":"2000","unstructured":"Bottlender R, Rudolf D, Strauss A, et al.: Are low basal serum levels of the thyroid stimulating hormone (b-TSH) a risk factor for switches into states of expansive syndromes (known in Germany as \u201cmaniform syndromes\u201d in bipolar I depression)? Pharmacopsychiatry 2000, 33:75\u201377.","journal-title":"Pharmacopsychiatry"},{"key":"157_CR29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/01.jcp.0000169037.17884.79","volume":"25","author":"MP Szuba","year":"2005","unstructured":"Szuba MP, Amsterdam JD, Fernando AT 3\u00a0rd, et al.: Rapid antidepressant response after nocturnal TRH administration in patients with bipolar type I and bipolar type II major depression. J Clin Psychopharmacol 2005, 25:325\u2013330.","journal-title":"J Clin Psychopharmacol"},{"key":"157_CR30","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1399-5618.2007.00507.x","volume":"9","author":"JR Calabrese","year":"2007","unstructured":"Calabrese JR, Guelfi JD, Perdrizet-Chevallier C: Agomelatine adjunctive therapy for acute bipolar depression: preliminary open data. Bipolar Disord 2007, 9:628\u2013635.","journal-title":"Bipolar Disord"},{"key":"157_CR31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.psychres.2007.11.020","volume":"165","author":"V Srinivasan","year":"2009","unstructured":"Srinivasan V, Pandi-Perumal SR, Trakht I, et al.: Pathophysiology of depression: role of sleep and the melatonergic system. Psychiatry Res 2009, 165:201\u2013214.","journal-title":"Psychiatry Res"},{"key":"157_CR32","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1399-5618.2007.00451.x","volume":"9","author":"D Sit","year":"2007","unstructured":"Sit D, Wisner KL, Hanusa BH, et al.: Light therapy for bipolar disorder: a case series in women. Bipolar Disord 2007, 9:918\u2013927.","journal-title":"Bipolar Disord"},{"key":"157_CR33","first-page":"1181","volume":"18","author":"RM Post","year":"2006","unstructured":"Post RM, Leverich GS: The role of psychosocial stress in the onset and progression of bipolar disorder and its comorbidities: the need for earlier and alternative modes of therapeutic intervention. Dev Psychopathol 2006, 18:1181\u20131211.","journal-title":"Dev Psychopathol"},{"key":"157_CR34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.comppsych.2009.05.005","volume":"51","author":"N Horesh","year":"2010","unstructured":"\u2022 Horesh N, Iancu I: A comparison of life events in patients with unipolar disorder or bipolar disorder and controls. Compr Psychiatry 2010, 51:157\u2013164. The data from this study suggest that different psychological stressors may play a different role in the onset of a depressive episode and a manic\/hypomanic episode.","journal-title":"Compr Psychiatry"},{"key":"157_CR35","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.4088\/JCP.v67n0902","volume":"67","author":"K Gao","year":"2006","unstructured":"Gao K, Muzina D, Gajwani P, et al.: Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. J Clin Psychiatry 2006, 67:1327\u20131340.","journal-title":"J Clin Psychiatry"},{"issue":"Suppl 2","key":"157_CR36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/11318630-000000000-00000","volume":"23","author":"J Mendlewicz","year":"2009","unstructured":"Mendlewicz J: Disruption of the circadian timing systems: molecular mechanisms in mood disorders. CNS Drugs 2009, 23(Suppl 2):15\u201326.","journal-title":"CNS Drugs"},{"key":"157_CR37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4088\/JCP.08m04942gre","volume":"71","author":"SL McElroy","year":"2010","unstructured":"\u2022\u2022 McElroy SL, Weisler RH, Chang W, et al.: A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II). J Clin Psychiatry 2010, 71:163\u2013174. This is the largest randomized, double-blind, placebo-controlled study of antidepressant monotherapy in the acute treatment of bipolar depression. At a dose of paroxetine of 20\u00a0mg\/d, the manic\/hypomanic switching rate from paroxetine was low and similar to that of placebo.","journal-title":"J Clin Psychiatry"},{"key":"157_CR38","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/YIC.0b013e3280c28410","volume":"22","author":"V Agosti","year":"2007","unstructured":"Agosti V, Stewart JW: Efficacy and safety of antidepressant monotherapy in the treatment of bipolar-II depression. Int Clin Psychopharmacol 2007, 22:309\u2013311.","journal-title":"Int Clin Psychopharmacol"},{"key":"157_CR39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00004850-198910000-00006","volume":"4","author":"JB Cohn","year":"1989","unstructured":"Cohn JB, Collins G, Ashbrook E, et al.: A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder. Int Clin Psychopharmacol 1989, 4:313\u2013322.","journal-title":"Int Clin Psychopharmacol"},{"key":"157_CR40","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1176\/appi.ajp.2009.09020284","volume":"167","author":"JD Amsterdam","year":"2010","unstructured":"\u2022\u2022 Amsterdam JD, Shults J: Efficacy and safety of long-term fluoxetine versus lithium monotherapy of bipolar II disorder: a randomized, double-blind, placebo-substitution study. Am J Psychiatry 2010, 167:792\u2013800. This is the largest study of antidepressant (fluoxetine) monotherapy in the acute and continuation treatment of bipolar II depression. At a dose of fluoxetine of 10 to 50\u00a0mg\/d, the hypomanic switching rate was similar to that of placebo. Because the sample size was small, it is difficult to draw a firm conclusion.","journal-title":"Am J Psychiatry"},{"key":"157_CR41","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1176\/appi.ajp.158.6.906","volume":"158","author":"CB Nemeroff","year":"2001","unstructured":"Nemeroff CB, Evans DL, Gyulai L, et al.: Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001, 158:906\u2013912.","journal-title":"Am J Psychiatry"},{"key":"157_CR42","doi-asserted-by":"crossref","first-page":"611","DOI":"10.4088\/JCP.v66n0511","volume":"66","author":"P Keck Jr","year":"2005","unstructured":"Keck P Jr, Corya S, Altshuler L, et al.: Analyses of treatment-emergent mania with olanzapine\/fluoxetine combination in the treatment of bipolar depression. J Clin Psychiatry 2005, 66:611.","journal-title":"J Clin Psychiatry"},{"key":"157_CR43","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa064135","volume":"356","author":"GS Sachs","year":"2007","unstructured":"Sachs GS, Nierenberg AA, Calabrese JR, et al.: Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007, 356:1711\u20131722.","journal-title":"N Engl J Med"},{"key":"157_CR44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1034\/j.1600-0447.2001.00240.x","volume":"104","author":"T Silverstone","year":"2001","unstructured":"Silverstone T: Moclobemide vs. imipramine in bipolar depression: a multicentre double-blind clinical trial. Acta Psychiatr Scand 2001, 104:104\u2013109.","journal-title":"Acta Psychiatr Scand"},{"key":"157_CR45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00004714-199812000-00003","volume":"18","author":"JD Amsterdam","year":"1998","unstructured":"Amsterdam JD, Garcia-Espana F, Fawcett J, et al.: Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J Clin Psychopharmacol 1998, 18:435\u2013440.","journal-title":"J Clin Psychopharmacol"},{"key":"157_CR46","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1176\/ajp.148.7.910","volume":"148","author":"JM Himmelhoch","year":"1991","unstructured":"Himmelhoch JM, Thase ME, Mallinger AG, et al.: Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991, 148:910\u2013916.","journal-title":"Am J Psychiatry"},{"key":"157_CR47","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1192\/bjp.bp.105.013045","volume":"189","author":"RM Post","year":"2006","unstructured":"Post RM, Altshuler LL, Leverich GS, et al.: Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry 2006, 189:124\u2013131.","journal-title":"Br J Psychiatry"},{"key":"157_CR48","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4088\/JCP.v63n0607","volume":"63","author":"E Vieta","year":"2002","unstructured":"Vieta E, Martinez-Aran A, Goikolea JM, et al.: A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry 2002, 63:508\u2013512.","journal-title":"J Clin Psychiatry"},{"key":"157_CR49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1176\/appi.ajp.163.2.232","volume":"163","author":"GS Leverich","year":"2006","unstructured":"Leverich GS, Altshuler LL, Frye MA, et al.: Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 2006, 163:232\u2013239.","journal-title":"Am J Psychiatry"},{"key":"157_CR50","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1017\/S1461145708009735","volume":"12","author":"E Brown","year":"2009","unstructured":"Brown E, Dunner DL, McElroy SL, et al.: Olanzapine\/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression. Int J Neuropsychopharmacol 2009, 12:773\u2013782.","journal-title":"Int J Neuropsychopharmacol"},{"key":"157_CR51","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1399-5618.2007.00500.x","volume":"10","author":"JR Calabrese","year":"2008","unstructured":"Calabrese JR, Huffman RF, White RL, et al.: Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 2008, 10:323\u2013333.","journal-title":"Bipolar Disord"},{"key":"157_CR52","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1399-5618.2003.00067.x","volume":"5","author":"JF Goldberg","year":"2003","unstructured":"Goldberg JF, Truman CJ: Antidepressant-induced mania: an overview of current controversies. Bipolar Disord 2003, 5:407\u2013420.","journal-title":"Bipolar Disord"},{"key":"157_CR53","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1399-5618.2008.00637.x","volume":"10","author":"K Gao","year":"2008","unstructured":"Gao K, Kemp DE, Ganocy SJ, et al.: Treatment-emergentthyc=5?> mania\/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder. Bipolar Disord 2008, 10:907\u2013915.","journal-title":"Bipolar Disord"}],"container-title":["Current Psychiatry Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-010-0157-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11920-010-0157-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11920-010-0157-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T23:27:41Z","timestamp":1559690861000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11920-010-0157-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,29]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["157"],"URL":"https:\/\/doi.org\/10.1007\/s11920-010-0157-z","relation":{},"ISSN":["1523-3812","1535-1645"],"issn-type":[{"value":"1523-3812","type":"print"},{"value":"1535-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,29]]}}}